“…3,5,7 Some authors suggest that radical surgery should be performed due to the more aggressive behavior of vagina melanoma. 8,9 After surgery, patients with a high risk of recurrence (including regional lymph node involvement or thicker primary tumors, i.e. American Joint Committee on Cancer Stage IIb/IIc/ III) should be considered for adjuvant therapy.…”
Malignant melanoma of the vagina, a very rare malignancy, has a notoriously aggressive behavior associated with a high risk of local recurrence and distant metastasis. At present, there are various treatment options for this disease but no standard guideline. We describe a case of a 54-year-old woman with a locally advanced melanoma of the vagina, who underwent radical surgery, biochemotherapy with interferon-α-2b, chemotherapy, radiotherapy, and repeat excision of local recurrent lesions and brain metastasis. In conclusion, malignant melanoma of the vagina has a high risk for local recurrence. Repeated local excision followed by biochemotherapy is a tolerable treatment.
“…3,5,7 Some authors suggest that radical surgery should be performed due to the more aggressive behavior of vagina melanoma. 8,9 After surgery, patients with a high risk of recurrence (including regional lymph node involvement or thicker primary tumors, i.e. American Joint Committee on Cancer Stage IIb/IIc/ III) should be considered for adjuvant therapy.…”
Malignant melanoma of the vagina, a very rare malignancy, has a notoriously aggressive behavior associated with a high risk of local recurrence and distant metastasis. At present, there are various treatment options for this disease but no standard guideline. We describe a case of a 54-year-old woman with a locally advanced melanoma of the vagina, who underwent radical surgery, biochemotherapy with interferon-α-2b, chemotherapy, radiotherapy, and repeat excision of local recurrent lesions and brain metastasis. In conclusion, malignant melanoma of the vagina has a high risk for local recurrence. Repeated local excision followed by biochemotherapy is a tolerable treatment.
“…Geisler et al advised primary pelvic exenteration for vaginal melanoma over 3 mm of invasion and showed that 50% 5-year survival rate might be obtained if the pelvic nodes were free of metastases [10]. Chung and Ariel, with separate series of 19 and 48 patients, respectively, defend the opinion that the appropriate management of this disease requires radical extirpation of the vagina supplemented by dissection of the regional lymphatics [11,12].…”
“…Les donné es sont insuffisantes pour é tablir des recommandations. L'amé lioration du contrô le local et de la survie par une chirurgie pelvienne radicale allant jusqu'à l'exenté ration est dé fendue par plusieurs auteurs [16] Toutefois, le bé né fice en termes de survie n'est pas significatif dans les plus grandes sé ries [6][7][8]. La situation est similaire dans le mé lanome ano-rectal.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.